Detection of autoantibodies to annexin A11 in different types of human cancer

被引：0

作者：

Song J. ^{[1
]}

Sun X. ^{[1
]}

Sokoll L.J. ^{[1
]}

Maki M. ^{[2
]}

Tian Y. ^{[1
]}

Chan D.W. ^{[1
]}

Zhang Z. ^{[1
,3
]}

机构：

[1] Center for Biomarker Discovery, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD

[2] Department of Applied Molecular Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa-ku, Nagoya, Furo-cho

[3] Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231

来源：

Clinical Proteomics | 2009年 / 5卷 / 2期

关键词：

Annexin A11; Autoantibody; Cancer; Enzyme-linked immunosorbent assay;

D O I：

10.1007/s12014-009-9031-6

中图分类号：

学科分类号：

摘要：

Introduction: Annexin A11 was previously identified as an autoantigen in 4.1-10.1% of patients with various systemic autoimmune diseases. In this study, an enzyme-linked immunosorbent assay (ELISA) was developed to investigate the occurrence and features of anti-annexin A11 autoantibodies in sera from patients with different types of cancer. Methods: The recombinant protein of GST fused to the N-terminal domain (1-175 residues) of human annexin A11 was expressed and used as antigen in ELISA. A total of 246 serum specimens were analyzed, which includes sera from healthy women (77), patients with ovarian cancer (72), breast cancer (18), colon cancer (19), pancreatic cancer (20), prostate cancer (20), and diabetes (20). Results: The overall titer of anti-annexin A11 autoantibodies in ovarian cancer patients (or primary tumors only) was found much higher than that in healthy controls (P<0.05). At the cut-off value designating positive reaction, anti-annexin A11 autoantibodies were detected in 12.5% (5/40) of primary ovarian cancer patients with a significant difference from 2.6% (2/77) of the healthy controls (P<0.05), but only in 6.25% (2/32) of recurrent tumors. ROC curve demonstrated the potential diagnostic value of anti-annexin A11 autoantibodies in primary ovarian cancer patients with an AUC of 0.62 (0.52-0.73). Anti-annexin A11 autoantibodies were also detected in 5.26% (1/19) of colon cancer and 10% (2/20) of diabetes patients but without significant difference from the healthy controls. Conclusion: A convenient assay to detect anti-annexin A11 autoantibodies in patients was developed, and the experimental data are promising but need to be expanded to address their biological/clinical relevance. © 2009 Humana Press.

引用

页码：125 / 131

页数：6

共 24 条

[1]

Old L.J., Chen Y.-T., New paths in human cancer serology, Journal of Experimental Medicine, 187, 8, pp. 1163-1167, (1998)

[2]

Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., Pfreundschun M., Human neoplasms elicit multiple specific immune responses in the autologous host, Proceedings of the National Academy of Sciences of the United States of America, 92, 25, pp. 11810-11813, (1995)

[3]

Soussi T., P53 Antibodies in the sera of patients with various types of cancer: A review, Cancer Res, 60, 7, pp. 1777-1788, (2000)

[4]

Brichory F.M., Misek D.E., Yim A.-M., Krause M.C., Giordano T.J., Beer D.G., Hanash S.M., An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer, Proceedings of the National Academy of Sciences of the United States of America, 98, 17, pp. 9824-9829, (2001)

[5]

Chetcuti A., Margan S.H., Russell P., Et al., Loss of annexin II heavy and light chains in prostate cancer and its precursors, Cancer Res, 61, 17, pp. 6331-6334, (2001)

[6]

Monastyrskaya K., Babiychuk E.B., Hostettler A., Rescher U., Draeger A., Annexins as intracellular calcium sensors, Cell Calcium, 41, 3, pp. 207-219, (2007)

[7]

Fernandez M.P., Jenkins N.A., Gilbert D.J., Copeland N.G., Morgan R.O., Sequence and chromosomal localization of mouse annexin XI, Genomics, 37, 3, pp. 366-374, (1996)

[8]

Furge L.L., Chen K., Cohen S., Annexin VII and annexin XI are tyrosine phosphorylated in peroxovanadate-treated dogs and in platelet-derived growth factor-treated rat vascular smooth muscle cells, J Biol Chem, 274, 47, pp. 33504-33509, (1999)

[9]

Jorgensen C.S., Levantino G., Houen G., Et al., Determination of autoantibodies to annexin XI in systemic autoimmune diseases, Lupus, 9, 7, pp. 515-520, (2000)

[10]

Misaki Y., Pruijn G.J., Van Der Kemp A.W., Van Venrooij W.J., The 56K autoantigen is identical to human annexin XI, J Biol Chem, 269, 6, pp. 4240-4246, (1994)

← 1 2 3 →